Next-Generation Ultrafast Photoluminescence Spectroscopy: Integration of Transient Grating Optical Gate and Advanced Femtosecond Laser Technology.

We demonstrate a high-performance ultrafast broadband time-resolved photoluminescence (TRPL) system based on the transient grating photoluminescence spectroscopy (TGPLS) technique. The core of the system is a Kerr effect-induced transient grating (TG) optical gate driven by high repetition rate ultrashort laser pulses at 1030 nm with micro-Joule pulse energy. Satisfying the demands of spectroscopy applications, the setup achieves high sensitivity, rapid data acquisition, ultrafast time resolution, and a wide spectral window from ultraviolet to near-infrared.

Determination of the carrier temperature in weakly confined semiconductor nanocrystals using time-resolved optical spectroscopy.

Many applications of nanocrystals rely on their use in light detection and emission. In recent years, nanocrystals with more relaxed carrier confinement, including so-called 'bulk' and 2D implementations, have made their stake. In such systems, the charge carriers generated after (photo-)excitation are spread over a semi-continuous density of states, behaviour controlled by the carrier temperature .

Durable lymphocyte subset elimination upon a single dose of AAV-delivered depletion antibody dissects immune control of chronic viral infection.

To interrogate the role of specific immune cells in infection, cancer, and autoimmunity, immunologists commonly use monoclonal depletion antibodies (depletion-mAbs) or genetically engineered mouse models (GEMMs). To generate a tool that combines specific advantages and avoids select drawbacks of the two methods, we engineered adeno-associated viral vectors expressing depletion mAbs (depletion-AAVs). Single-dose depletion-AAV administration durably eliminated lymphocyte subsets in mice and avoided accessory deficiencies of GEMMs, such as marginal zone defects in B cell-deficient animals.

Effect of oral nintedanib vs placebo on epistaxis in hereditary hemorrhagic telangiectasia: the EPICURE multicenter randomized double-blind trial.

Epistaxis greatly affects patients with hereditary hemorrhagic telangiectasia (HHT). Although few systemic treatment exist, nintedanib, is a good candidate thanks to its anti-angiogenic activity. Our main objective was to evaluate the efficacy of oral nintedanib on epistaxis duration in HHT patients with moderate to severe epistaxis.